Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1111 of 6351
-
RNA vaccine shows promise in advanced melanoma trial
Vaccine CompletedThe purpose of this study is to determine the safety and tolerability of intravenous administration of a tetravalent RNA-lipoplex cancer vaccine targeting four tumor-associated antigens in patients with advanced melanoma.
Phase 1 • Sponsor: BioNTech SE • Aim: Vaccine
Last updated Jun 27, 2026 11:01 UTC
-
Baby teeth stem cells may spare kids a second surgery for cleft palate repair
Symptom relief CompletedStudy Objective The objective of this study was to evaluate and compare postoperative pain and hospital costs in pediatric patients with cleft lip and palate undergoing alveolar bone grafting surgery. The study compared a new tissue engineering approach against the traditional su…
Phase 1/2 • Sponsor: Hospital Sirio-Libanes • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can a common blood thinner stop silent heart attacks?
Disease control CompletedHeart attacks are most commonly caused by rupture of fatty deposits (plaques) within the wall of heart blood vessels. It appears that this process can also frequently occur without causing any symptoms and these events likely explain the development of narrowing within the heart …
Phase 2/3 • Sponsor: University of Edinburgh • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Hand transplants get a boost: new drug may reduce rejection risk
Disease control Recruiting nowThe purpose of this study is to determine the safety and efficacy of hand transplantation as a treatment for patients with loss of limb below the elbow, The study will focus on patients who have had loss of limb. The primary endpoint is the ability to use the tranplanted limb in …
Phase 2 • Sponsor: Linda Cendales • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New combo therapy shows promise for aggressive blood cancer
Disease control CompletedThe purpose of phase 1 part in this study was to determine the maximum tolerated dose (MTD) and/or recommended expansion dose (RED) of ASP2215 concomitant with cytarabine/idarubicin as induction chemotherapy based on the status of the onset of dose-limiting toxicity (DLT) in newl…
Phase 1/2 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Jun 26, 2026 13:17 UTC
-
Immunotherapy combo shows promise for Tough-to-Treat blood cancers
Disease control CompletedThis phase II trial studies how well pembrolizumab alone or with idelalisib or ibrutinib works in treating patients with chronic lymphocytic leukemia or other low-grade B-cell non-Hodgkin lymphomas that have returned after a period of improvement (relapsed) or have not responded …
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Donor T-Cells take on stubborn CMV in transplant patients
Disease control OngoingThis phase II trial studies how well donor cytomegalovirus-specific cytotoxic T-lymphocytes work in treating patients with a cytomegalovirus infection that has come back or has not gotten better despite standard therapy. White blood cells from donors who have been exposed to cyto…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New heart valve replacement offers hope for high-risk patients
Disease control OngoingStudy to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New cocktail aims to tame incurable head and neck cancer
Disease control OngoingThe purpose of this research study is to look at the effect of a treatment regimen called CACTUX on head and neck cancer. The CACTUX regimen is a combination of three drugs called cisplatin, nab-paclitaxel, and cetuximab (although carboplatin may be given in place of cisplatin if…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Video games vs eye patches: a new hope for lazy eye?
Disease control Ongoing1. To determine whether a binocular iPad game app is effective in improving visual acuity and reducing interocular suppression in amblyopic children 2. To compare the amount of visual acuity improvement achieved with the binocular game app to the amount achieved with patching (st…
Sponsor: Retina Foundation of the Southwest • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New drug cocktails show promise for multiple myeloma patients
Disease control CompletedThis study will evaluate the safety and the efficacy of carfilzomib combined with cyclophosphamide and dexamethasone (CCyd) or lenalidomide and dexamethasone (CRd) followed by autologous transplantation ASCT or 12 cycles of carfilzomib combined with dexamethasone and lenalidomide…
Phase 2 • Sponsor: Mario Boccadoro • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
HIV and hidden health risks: a major study probes the link
Knowledge-focused OngoingDespite efficient antiretroviral treatment for HIV infection, decrease in life expectancy remains. Excess mortality is mainly due to non-AIDS co-morbidity including cardiovascular, pulmonary, and liver related diseases. Both HIV-unrelated and HIV-related risk factors probably con…
Sponsor: Susanne Dam Nielsen, MD, DMSc • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Ovarian cancer vaccine trial aims to keep tumors at bay
Disease control OngoingThe goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated with investigational product (Vigil) compared to placebo. The main question it aims to answer is "Will participants who receive treatment with Vigil h…
Phase 2 • Sponsor: Gradalis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug shows promise for rare movement disorder
Disease control CompletedIn this study, researchers are learning more about RTA 408, also known as omaveloxolone, BIIB141, or SKYCLARYS®. The main goal of this study is to learn more about the safety of RTA 408 and how it affects physical effort, movement, coordination, and how participants feel in daily…
Phase 2 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can smarter epidural delivery ease labour pain better?
Symptom relief OngoingEpidural analgesia is the gold standard of pain relief for labour pain. Despite this, more than 50% of parturients continue to experience pain leading to suffering and increased caregiver workload. Women who have increased pain tend to have lower successful patient bolus demands …
Phase 3 • Sponsor: KK Women's and Children's Hospital • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Immunotherapy after standard care may delay lung cancer return
Disease control CompletedThe main purpose of this study is to see how well the experimental drug pembrolizumab (MK-3475) works in people with oligometastatic NSCLC who have already had treatment for their disease. All patients will receive 200 mg of pembrolizumab intravenously on Day 1 of each 21-day cyc…
Phase 2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug cocktail aims to keep myeloma in check after transplant
Disease control OngoingThe purpose of this research study is to evaluate a treatment regimen called IRD which will be given to participants after their stem cell transplant in an effort to help prolong the amount of time the participants are disease-free after transplant. IRD is a three-drug regimen co…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can Hands-On ergonomic training outsmart back pain in warehouse workers?
Prevention CompletedBackground: Musculoskeletal disorders are common occupational health problems among industrial workers, particularly manual material handlers involved in repetitive lifting and physical tasks. Ergonomic education and postural awareness interventions are frequently used to preven…
Sponsor: Okan University • Aim: Prevention
Last updated Aug 06, 2026 00:00 UTC
-
Double attack: radiation plus chemo shows promise for rare lymphoma
Disease control OngoingThe goal of this clinical research study is to learn if radiation therapy and chemotherapy can help control Stage 1 and/or 2 NK cell lymphoma. The safety of the radiation and chemotherapy combination will also be studied. This is an investigational study. Radiation and chemother…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New radiation approach aims to tame prostate cancer with fewer side effects
Disease control CompletedThis trial studies the side effects and how well high-dose brachytherapy works in treating patients with prostate cancer that has not spread to other parts of the body. Brachytherapy is a type of radiation therapy in which radioactive material sealed in needles, seeds, wires, or …
Sponsor: Stanford University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC